Home
Piramal Pharma Ltd 52 Week Low

Piramal Pharma Ltd
NSE: PPLPHARMA
YEARLOW
Key Highlights
- The 52 Week Low of Piramal Pharma Ltd is ₹ 114.45 as of 21 Feb 25 .
Company Fundamentals for Piramal Pharma Ltd
Market Price of Piramal Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 208.6 |
20 Feb 2025 | 218.05 |
19 Feb 2025 | 200.45 |
18 Feb 2025 | 197.65 |
17 Feb 2025 | 199.85 |
14 Feb 2025 | 184.8 |
13 Feb 2025 | 200.9 |
12 Feb 2025 | 200.2 |
11 Feb 2025 | 204.35 |
10 Feb 2025 | 221.1 |
Asset Value vs Market Value of Piramal Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Piramal Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Piramal Pharma Ltd
Historical Net Profit of Piramal Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Piramal Pharma Ltd
Piramal Pharma Ltd News Hub
Piramal Pharma receives SBTi validation for its GHG commitment
Piramal Pharma has embarked on its sustainability journey as the Science Based Targets initiative (S
Read more
17 Sept 24
Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization
Read more
30 Sept 24
Piramal Pharma to discuss results
Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe
Read more
14 Jan 25
Piramal Pharma to declare Quarterly Result
Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October 2024. Powe
Read more
15 Oct 24